Efficacy of Olprinone Hydrochloride During Pulmonary Resection for Lung Cancer

Efficacy of Olprinone Hydrochloride During Pulmonary Resection for Lung Cancer - Efficacy of Olprinone Hydrochloride During Lung Cancer Surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002404

Enrollment

Registered

2009-08-30

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Infusion of olprinone hydrochloride group Control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo pulmonary resection for lung cancer and preoperative BNP levels of 30pg/mL or more

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
whether infusion of olprinone hydrochloride during pulmonary resection has an effect on the reduction of postoperative atrial fibrillation	—

Secondary

Measure	Time frame
Anti-inflammatory effect The change of perioperative cathecolamine levels after pulmonary resection	—

Countries

Japan

Contacts

Public ContactTakashi Nojiri

Toneyama National Hospital General Thoracic Surgery

nojiri@ri.ncvc.go.jp06-6853-2001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026